Evidence map›Paper›PMID 36834496›Full record

ReviewInternational journal of molecular sciences2023

Nrf2 and Antioxidant Response in Animal Models of Type 2 Diabetes.

R Paul Robertson

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. [Diabetic Nephropathy Treatment by Zn Supplementation in a Murine Model of Type 1 Diabetes Mellitus: Potential Role of Nrf2 Signaling Pathway].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Article
  6. Matrine Alleviates Oxidative Stress and Inflammation in Colon Cancer by Activating the Nrf2 Pathway.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Novel lipid mediator 7Frontiers in cell and developmental biology · 2024
    Article
  11. Review
  12. Redox Systems Biology in Chronic Kidney Disease.Oxidative medicine and cellular longevity · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

R Paul RobertsonDivision of Metabolism, Endocrinology and Nutrition, Department of Internal Medicine, University of Washington, Seattle, WA 98105, USA.
University of Washington · US

Funding

PGE RECEPTOR - LIVER AND FAT METABOLISMR01DK038325 · NIDDK · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ROBERTSON, RODERICK PAUL · 1986 to 2010
$3.6M
NIDDK NIH HHS R01 DK038325
6 · The paper itself

Abstract

This perspective examines the proposition that chronically elevated blood glucose levels caused by type 2 diabetes (T2D) harm body tissues by locally generating reactive oxygen species (ROS). A feed-forward scenario is described in which the initial onset of defective beta cell function T2D becomes sustained and causes chronic elevations in blood glucose, which flood metabolic pathways throughout the body, giving rise to abnormally high local levels of ROS. Most cells can defend themselves via a full complement of antioxidant enzymes that are activated by ROS. However, the beta cell itself does not contain catalase or glutathione peroxidases and thereby runs a greater risk of ROS-induced damage. In this review, previously published experiments are revisited to examine the concept that chronic hyperglycemia can lead to oxidative stress in the beta cell, how this relates to the absence of beta cell glutathione peroxidase (GPx) activity, and whether this deficiency might be ameliorated by genetic enrichment of beta cell GPx and by oral antioxidants, including ebselen, a GPx mimetic.

Indexed as

AntioxidantsDiabetes Mellitus, Type 2AnimalsBlood GlucoseGlutathione PeroxidaseModels, AnimalNF-E2-Related Factor 2Oxidative StressReactive Oxygen SpeciesAntioxidantsBlood GlucoseGlutathione PeroxidaseNF-E2-Related Factor 2Reactive Oxygen Speciesantioxidant responseNrf2type 2 diabetes in animals

Identifiers

PMID36834496
PMCPMC9961396
OpenAlexW4319318445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.